RAF1 exerts dual roles in STAT3 activation; in hepatocellular carcinoma, RAF1 acts as a cell-autonomous tumor suppressor by negatively regulating STAT3 activation [60], while it has been described as a STAT3 activator in squamous cell carcinoma through its interaction with ROKα [8]. Here, STAT3 is linked to hepatocellular carcinoma.